Erling O. Emerson
- Oncology
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging
- Organic Chemistry
- Pulmonary and Respiratory Medicine
- Co-authors
- Jitesh P. JaniJohn C. KathLeslie R. PustilnikAnn Marie RossiJames D. MoyerV. D. GuptaBing XuHoward A. Zaren
- Topics
- Drug Transport and Resistance Mechanisms (4 papers)Cancer therapeutics and mechanisms (3 papers)HER2/EGFR in Cancer Research (2 papers)
- Partner nations
- United StatesSwitzerland
In The Last Decade
Erling O. Emerson
7 papers receiving 145 citations
Peers
Comparison fields: 5 of 42
- Oncology 87
- Molecular Biology 78
- Radiology, Nuclear Medicine and Imaging 33
- Organic Chemistry 22
- Pulmonary and Respiratory Medicine 15
Countries citing papers authored by Erling O. Emerson
This map shows the geographic impact of Erling O. Emerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erling O. Emerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erling O. Emerson more than expected).
Fields of papers citing papers by Erling O. Emerson
This network shows the impact of papers produced by Erling O. Emerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erling O. Emerson. The network helps show where Erling O. Emerson may publish in the future.
Co-authorship network of co-authors of Erling O. Emerson
This figure shows the co-authorship network connecting the top 25 collaborators of Erling O. Emerson. A scholar is included among the top collaborators of Erling O. Emerson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erling O. Emerson. Erling O. Emerson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 62 | |
| 3 | The biological and biochemical effects of CP-654577, a selective erbB2 kinase inhibitor, on human breast cancer cells. | 40 |
| 4 | 14 | |
| 5 | 18 | |
| 6 | 3 | |
| 7 | 11 |
About Erling O. Emerson
Erling O. Emerson is a scholar working on Toxicology, Oncology and Genetics, having authored 7 papers that have together received 151 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (4 papers), Cancer therapeutics and mechanisms (3 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Oncology (87 citations), Toxicology (8 citations) and Radiology, Nuclear Medicine and Imaging (33 citations). Erling O. Emerson has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Jitesh P. Jani, John C. Kath, Leslie R. Pustilnik, Ann Marie Rossi, James D. Moyer, V. D. Gupta, Bing Xu, Howard A. Zaren, Zhengyu Liu and Joel Morris. Their work appears in journals such as Cancer Research, International Journal of Cancer and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.